Ironwood Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ironwood Pharmaceuticals generated cash of $183,427,000, which is less than the previous year. Cash used in financing activities reached the amount of $277,160,000 last year. Net change in cash is therefore -$565,784,000.
Cash Flow
| 2014 | -155.56M | -56.56M | 210.94M |
|---|---|---|---|
| 2015 | -106.92M | -9.15M | 303.07M |
| 2016 | -25.43M | -177.67M | -4.17M |
| 2017 | -99.56M | 151.46M | 19.83M |
| 2018 | -70.88M | 88.86M | 30.07M |
| 2019 | 10.72M | -11.14M | -1.18M |
| 2020 | 168.83M | -1.84M | 18.54M |
| 2021 | 261.89M | -265K | -4.55M |
| 2022 | 273.76M | -136K | -237.55M |
| 2023 | 183.42M | -1.02B | 277.16M |
IRWD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 657.93M | 621.86M | 364.78M | 179.24M | 180.84M | 132.79M | 54.00M | 261.28M | 74.29M | 75.49M |
Operating activities | ||||||||||
Net income | -1.00B | 175.06M | 528.44M | 106.17M | 21.50M | -282.36M | -116.93M | -81.70M | -142.66M | -189.61M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.57M | 1.41M | 1.52M | 3.56M | 5.58M | 14.22M | 14.61M | 11.26M | 11.63M | 12.33M |
Stock-based compensation expense | 32.00M | 27.04M | 22.28M | 31.17M | 31.27M | 0 | 33.82M | 29.21M | 25.46M | 26.18M |
| Deferred income tax benefit | 32.00M | 27.04M | 22.28M | 31.17M | 31.27M | 0 | 33.82M | 29.21M | 25.46M | 26.18M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 924K | 7.99M | 7.71M | 4.09M | -68.89M | 1.20M | -17.30M | -10.33M | -28.67M | -23.68M |
Inventories | 0 | 0 | 0 | 648K | 725K | -806K | 346K | 1.26M | 3.65M | -3.07M |
Accounts payable | 12.38M | -8.11M | -2.64M | -7.52M | -32.7M | 8.05M | -6.84M | 19.68M | -1.55M | 1.42M |
Cash generated by operating activities | 183.42M | 273.76M | 261.89M | 168.83M | 10.72M | -70.88M | -99.56M | -25.43M | -106.92M | -155.56M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -3.24M | -191.35M | -311.11M | -281.95M | -253.99M |
Investments In Property Plant And Equipment | -273K | -136K | -265K | -1.84M | -7.18M | -8.62M | -4.21M | -104.20M | -4.04M | -3.53M |
Acquisitions Net | -1.02B | 0 | 0 | 0 | 268K | 0 | 135K | 100M | 147K | 0 |
Cash generated by investing activities | -1.02B | -136K | -265K | -1.84M | -11.14M | 88.86M | 151.46M | -177.67M | -9.15M | -56.56M |
Financing activities | ||||||||||
Common Stock Issued | 6.35M | 0 | 19.58M | 18.54M | 13.59M | 0 | 26.37M | 0 | 14.19M | 190.42M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -126.39M | -24.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 300M | -120.69M | 0 | 0 | 7.20M | -1.82M | 8.75M | -28.77M | 321.67M | -2.22M |
Cash used in financing activities | 277.16M | -237.55M | -4.55M | 18.54M | -1.18M | 30.07M | 19.83M | -4.17M | 303.07M | 210.94M |
Net Change In Cash | -565.78M | 36.07M | 257.08M | 185.54M | -1.60M | 48.05M | 71.73M | -207.28M | 186.99M | -1.19M |
Cash at end of period | 92.15M | 657.93M | 621.86M | 364.78M | 179.24M | 180.84M | 125.73M | 54.00M | 261.28M | 74.29M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |